Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Affiliations

• ¹ Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway. Electronic address: marius.troseid@medisin.uio.no.
• ² HIV/AIDS Research Unit, Geneva University Hospitals, Geneva, Switzerland.
• ³ Département des Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon Lyon, France.
• ⁴ Lab. De Pesquisa Clinica DST/AIDS, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
• ⁵ Infectious Diseases Unit, Hospital La Paz, Madrid, Spain.
• ⁶ Infectious Diseases Department, Saint-Louis APHP, Paris, France.
• ⁷ Division of Infectious Diseases, University Hospital, Zurich, Switzerland.
• ⁸ Cliniques Universitaires de Bruxelles-Hôpital Érasme, Université Libre de Bruxelles, Clinique des Maladies Infectieuses, Brussels, Belgium.
• ⁹ CHU de Bordeaux and Université de Bordeaux, INSERM U1219, F-33000 Bordeaux, France.
• ¹⁰ Infectious Diseases Service, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
• ¹¹ Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
• ¹² Dept. of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway.
• ¹³ Université de Paris, IAME, INSERM, Paris, France.